A Study Evaluating ABI-H0731+ Entecavir vs Entecavir Alone for the Treatment of Viremic HBeAg-positive Participants With Chronic Hepatitis B Virus Infection (cHBV)

计划入组 25 人 · 首次发布于 2018 年 7 月 5 日

Rapid T-cell Analysis Test in Patients With Chronic HBV and HBV/HDV Disease

计划入组 300 人 · 首次发布于 2024 年 4 月 18 日

A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB

计划入组 450 人 · 首次发布于 2015 年 11 月 26 日

HBV

ChAdOx1-HBV

MBS-HBV

Centre Hospitalier Universitaire Vaudois (CHUV)

Switzerland

CHV Home Medical Equipment Company, LLC

United States

Arbutus Biopharma Advances cHBV Program with Imdusiran Phase 2b Trial Initiation Planned for 2025

Arbutus Biopharma's Imdusiran Shows Promise in Hepatitis B Functional Cure

Imdusiran, VTP-300, and Nivolumab Combination Shows Promise in Chronic Hepatitis B